These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2719046)

  • 41. By the numbers. Top 20 pharmaceutical companies ranked by U.S. sales, November 2003 to October 2004.
    Moon S
    Mod Healthc; 2005 Jan; 35(1):32. PubMed ID: 15693520
    [No Abstract]   [Full Text] [Related]  

  • 42. Top 20 pharmaceutical companies. Ranked by U.S. sales, October 2008 to September 2009.
    Mod Healthc; 2010 Jan; 40(1):31. PubMed ID: 20088280
    [No Abstract]   [Full Text] [Related]  

  • 43. Drug information residency rotation with pharmaceutical industry.
    Cramer RL
    Am J Pharm Educ; 1986; 50(2):154-6. PubMed ID: 10277398
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Largest pharmaceutical companies. Ranked by U.S. retail sales, December 2009 to November 2010.
    Mod Healthc; 2011 Jan; 41(1):33. PubMed ID: 21322350
    [No Abstract]   [Full Text] [Related]  

  • 45. By the numbers. Top 20 pharmaceutical companies ranked by U.S. sales, October 2006 to September 2007.
    Mod Healthc; 2008 Jan; 38(1):31. PubMed ID: 18271198
    [No Abstract]   [Full Text] [Related]  

  • 46. Top 20 pharmaceutical companies. Ranked by U.S. sales, October 2007 to September 2008.
    Mod Healthc; 2009 Jan; 39(1):32. PubMed ID: 19226860
    [No Abstract]   [Full Text] [Related]  

  • 47. Most drug freebies go to well-off: study. Research suggests race, gender a factor, too, but drug group calls research flawed.
    Rhea S
    Mod Healthc; 2008 Jan; 38(1):12-3. PubMed ID: 18273965
    [No Abstract]   [Full Text] [Related]  

  • 48. What information do physicians receive from pharmaceutical representatives?
    Lexchin J
    Can Fam Physician; 1997 May; 43():941-5. PubMed ID: 9154366
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Freebies for subject 641: a discussion of the ethical prospect of providing drug trial subjects with post-trial access to the drug tested--a Canadian perspective.
    Hutt LE
    Health Law J; 1998; 6 Spec No():169-87. PubMed ID: 14746066
    [TBL] [Abstract][Full Text] [Related]  

  • 50. By the numbers. Top 20 pharmaceutical companies. Ranked by U.S. sales, April 2003 through March 2004.
    Moon S
    Mod Healthc; 2004 Aug; 34(33):40. PubMed ID: 15356990
    [No Abstract]   [Full Text] [Related]  

  • 51. Pharmaceutical freebies.
    Ebell M
    Fam Pract Manag; 2002 Sep; 9(8):14; author reply 14. PubMed ID: 12375472
    [No Abstract]   [Full Text] [Related]  

  • 52. Top 20 pharmaceutical companies. Ranked by U.S. sales, December 2005 to November 2006.
    Mod Healthc; 2007 Jan; 37(2):33. PubMed ID: 17243346
    [No Abstract]   [Full Text] [Related]  

  • 53. Resuscitation and rescue of the pharmaceutical detail: a prescriber-drug representative collaboration.
    Kale SA; Barkin RL
    Compr Ther; 2009; 35(2):68-71. PubMed ID: 19618754
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comment: the economics of direct-to-consumer advertising of prescription-only drugs: prescribed to improve consumer welfare?
    Rosenthal M
    J Health Serv Res Policy; 2004 Jan; 9(1):39-42; discussion 41-2. PubMed ID: 15006239
    [No Abstract]   [Full Text] [Related]  

  • 55. Drug information services at Pfizer labs.
    Gasperino JL
    Am J Hosp Pharm; 1990 Sep; 47(9):1998-9. PubMed ID: 2220851
    [No Abstract]   [Full Text] [Related]  

  • 56. Drug information services at the Upjohn Company.
    Baker RP; Gurwich EL; Depew CC
    Am J Hosp Pharm; 1990 Sep; 47(9):1999-2001. PubMed ID: 2220852
    [No Abstract]   [Full Text] [Related]  

  • 57. [Is openness in the drug market possible?].
    Dölle W; Schwabe U
    Internist (Berl); 1986 Jan; 27(1):21-31. PubMed ID: 3514513
    [No Abstract]   [Full Text] [Related]  

  • 58. The pharmaceutical industry--to whom is it accountable?
    Schwarting JS
    N Engl J Med; 2000 Nov; 343(19):1416; discussion 1417. PubMed ID: 11183879
    [No Abstract]   [Full Text] [Related]  

  • 59. Keys to CRM success. How well are contract pharmaceutical companies doing in the CRM game?
    Kros JF; Molis J
    Mark Health Serv; 2004; 24(4):32-6. PubMed ID: 15612224
    [No Abstract]   [Full Text] [Related]  

  • 60. Information from drug companies and opinion leaders.
    Liberati A; Magrini N
    BMJ; 2003 May; 326(7400):1156-7. PubMed ID: 12775588
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.